Marketing Efforts Advancing Ablatherm-HIFU in Key Global Market

The following article appeared September 27, 2006 in WRAL.com serving the Raleigh-Durham & Fayetteville, North Carolina areas. The story can be viewed at http://www.wral.com/health/9947426/detail.html. Ultrasound Waves Being Used To Treat Prostate Cancer

Webcast: EDAP Presentation at Roth Capital Conference EDAP TMS S.A. (Nasdaq: EDAP), the global leader in High Intensity Focused Ultrasound (HIFU) treatment of prostate cancer, presented at the Roth Capital Partners New York Conference on September 6, 2006 at the Westin Time Square Hotel in New

EDAP TMS S.A. to Present at Roth Capital Conference in New York Lyon, France, August 24, 2006 - EDAP TMS S.A. (Nasdaq: EDAP) , the global leader in High Intensity Focused Ultrasound (HIFU) treatment of prostate cancer, announced management will present at the Roth Capital Partners New York

HIFU Utilization Increasing as Company Accelerates Its Growth Program Company Adding Resources to Launch RPP Centers More Quickly

EDAP TMS S.A. to Release 2006 Second Quarter Financial Results August 8, 2006 Lyon, France, August 3, 2006 - EDAP TMS S.A. (Nasdaq: EDAP) , will release its second quarter financial results for the period ending June 30, 2006 on Tuesday, August 8, 2006 after the market close.

Proceeds to Enhance Marketing to Accelerate Ablatherm-HIFU RPP Business in Europe

Increasing Sites and Utilization Rate Necessitates Third Unit; Market More Than Double Prior Year

New Site to Launch Fixed RPP Services Model; First Portuguese HIFU Center

Ablatherm FDA Study in Triangle Business Journal EDAP's Ablatherm-HIFU FDA clinical study was recently featured in the Triangle Business Journal. The article is viewable online at http://triangle.bizjournals.com/triangle/stories/2006/07/17/focus4.html  .  A patient treated at Duke University